DOES YOUR CHILD WHEEZE? JOIN OUR STUDY LOOKING AT A TREATMENT FOR ASTHMA AND BREATHING PROBLEMS!
K
Kirsten Kloepfer, MD
Primary Investigator
Not Recruiting
2-3 years
All
Phase
N/A
2 Locations
Brief description of study
Does your child experience breathing difficulties due to asthma, wheezing or allergies?
Researchers at Indiana University School of Medicine and Riley Children's Hospital are investigating a treatment for asthma in young children to determine if it:
Researchers at Indiana University School of Medicine and Riley Children's Hospital are investigating a treatment for asthma in young children to determine if it:
- Helps prevent asthma as children grow older;
- Lessens the severity of breathing problems;
- Stops young kids from developing new allergies or reduce existing allergies;
- Decreases wheezing during and after the treatment period.
Detailed description of study
Who Is Eligible
- Children 2-3 years of age
- Family history of asthma, allergies or eczema
- Had wheezing symptoms in the past year
What Is Involved
Children taking part in this study will be placed by random, like a flip of a coin, into one of two groups: a group that will receive the study drug Omalizumab (also known as Xolair) or a group that will receive a placebo.
Participants will receive this medicine by injection every 4 weeks for 2 years and will then be followed for an additional 2 years:
Years 1 and 2
- Receive an injection of either the study drug, Omalizumab, or placebo every 4 weeks.
Years 3 and 4
- Attend study visits every 4 months for clinical assessment, management of respiratory symptoms, and completion of study questionnaires
- Participate in monthly phone calls to assess how your child is doing.
- No injections will take place during years 3 and 4
Study visits will take place at Riley Children’s Clinical Research Center in Indianapolis.
Participants will be compensated for their time and could receive up to $2,560 for completed study visits and telephone calls.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: asthma,eczema,allergy,allergies
-
Age: Between 2 Years - 3 Years
-
Gender: All
Eligibility Criteria:
- Children 2-3 years of age
- Family history of asthma, allergies or eczema
- Had wheezing symptoms in the past year
Updated on
01 Aug 2024.
Study ID: 1911077578
